An Organometallic Compound which Exhibits a DNA Topology-Dependent One-Stranded Intercalation Mode.
暂无分享,去创建一个
U. Rothlisberger | G. Palermo | P. Dyson | C. Davey | B. Murray | Thibaud von Erlach | Zhujun Ma | Z. Adhireksan
[1] G. Davey,et al. Stereochemical control of nucleosome targeting by platinum-intercalator antitumor agents , 2015, Nucleic acids research.
[2] U. Rothlisberger,et al. Mixed Quantum Mechanical/Molecular Mechanical Molecular Dynamics Simulations of Biological Systems in Ground and Electronically Excited States. , 2015, Chemical reviews.
[3] U. Rothlisberger,et al. Ligand substitutions between ruthenium–cymene compounds can control protein versus DNA targeting and anticancer activity , 2014, Nature Communications.
[4] A. Rescifina,et al. Recent advances in small organic molecules as DNA intercalating agents: synthesis, activity, and modeling. , 2014, European journal of medicinal chemistry.
[5] G. Davey,et al. The mechanics behind DNA sequence-dependent properties of the nucleosome , 2012, Nucleic acids research.
[6] G. Davey,et al. Specific DNA structural attributes modulate platinum anticancer drug site selection and cross-link generation , 2011, Nucleic acids research.
[7] P. Dyson,et al. A ruthenium antimetastasis agent forms specific histone protein adducts in the nucleosome core. , 2011, Chemistry.
[8] P. Sadler,et al. Penetrative DNA intercalation and G-base selectivity of an organometallic tetrahydroanthracene RuII anticancer complex , 2010 .
[9] C. Davey,et al. Structural insight into the sequence dependence of nucleosome positioning. , 2010, Structure.
[10] U. Surana,et al. DNA stretching in the nucleosome facilitates alkylation by an intercalating antitumour agent , 2009, Nucleic acids research.
[11] J. Barton,et al. Metallo-intercalators and metallo-insertors. , 2007, Chemical communications.
[12] T. Richmond,et al. DNA stretching and extreme kinking in the nucleosome core. , 2007, Journal of molecular biology.
[13] Colin G. Barry,et al. Platinum-intercalator conjugates: from DNA-targeted cisplatin derivatives to adenine binding complexes as potential modulators of gene regulation. , 2004, Current topics in medicinal chemistry.
[14] J. Cummings,et al. In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer , 2002, British Journal of Cancer.
[15] P. Sadler,et al. Organometallic ruthenium(II) diamine anticancer complexes: arene-nucleobase stacking and stereospecific hydrogen-bonding in guanine adducts. , 2002, Journal of the American Chemical Society.
[16] S. Lippard,et al. 2.4 A crystal structure of an oxaliplatin 1,2-d(GpG) intrastrand cross-link in a DNA dodecamer duplex. , 2001, Inorganic chemistry.
[17] P. Sadler,et al. Conformation of DNA modified by monofunctional Ru(II) arene complexes: recognition by DNA binding proteins and repair. Relationship to cytotoxicity. , 2005, Chemistry & biology.